Survival curves data from the TCGA database indicated that patients with high SLC1A5 mRNA expression (n = 34) had significantly poorer overall survival compared with patients without altered SLC1A5 mRNA expression in ccRCC (p = 0.00002) (Figure 5). This evidence concerns the gene SLC1A5 and nonpapillary renal cell carcinoma.